Cargando…

Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration

(i) Background: Cognitive impairment in people with multiple sclerosis (MS) has been studied in relation to certain clinical variables (e.g., motor disability and disease duration) and lifestyle factors such as cognitive reserve (CR). However, only very few studies have considered the interaction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Maffezzini, Sabrina, Pucci, Veronica, Riccardi, Alice, Montemurro, Sonia, Puthenparampil, Marco, Perini, Paola, Rinaldi, Francesca, Gallo, Paolo, Arcara, Giorgio, Mondini, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525733/
https://www.ncbi.nlm.nih.gov/pubmed/37753986
http://dx.doi.org/10.3390/bs13090708
_version_ 1785110854949142528
author Maffezzini, Sabrina
Pucci, Veronica
Riccardi, Alice
Montemurro, Sonia
Puthenparampil, Marco
Perini, Paola
Rinaldi, Francesca
Gallo, Paolo
Arcara, Giorgio
Mondini, Sara
author_facet Maffezzini, Sabrina
Pucci, Veronica
Riccardi, Alice
Montemurro, Sonia
Puthenparampil, Marco
Perini, Paola
Rinaldi, Francesca
Gallo, Paolo
Arcara, Giorgio
Mondini, Sara
author_sort Maffezzini, Sabrina
collection PubMed
description (i) Background: Cognitive impairment in people with multiple sclerosis (MS) has been studied in relation to certain clinical variables (e.g., motor disability and disease duration) and lifestyle factors such as cognitive reserve (CR). However, only very few studies have considered the interaction of clinical variables and cognitive reserve in preserving the integrity of the neuropsychological profile. In this paper, we hypothesised that a higher level of CR might predict good cognitive efficiency by modulating the clinical outcome of the disease. (ii) Methods: A sample of 100 participants with MS (age range 30–74), was recruited and assessed remotely with a questionnaire to measure CR and a cognitive screening test. Data were analysed through generalized additive models. (iii) Results: We found that the model analysing the interaction between CR and disease duration, and between CR and motor disability, was able to explain a significant percentage of cognitive performance. In particular, higher levels of CR predicted a better cognitive performance despite a long disease duration, unless the motor disability was severe. (iv) Conclusion: This study highlights the crucial role of CR in modulating cognitive efficiency in people with MS.
format Online
Article
Text
id pubmed-10525733
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105257332023-09-28 Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration Maffezzini, Sabrina Pucci, Veronica Riccardi, Alice Montemurro, Sonia Puthenparampil, Marco Perini, Paola Rinaldi, Francesca Gallo, Paolo Arcara, Giorgio Mondini, Sara Behav Sci (Basel) Article (i) Background: Cognitive impairment in people with multiple sclerosis (MS) has been studied in relation to certain clinical variables (e.g., motor disability and disease duration) and lifestyle factors such as cognitive reserve (CR). However, only very few studies have considered the interaction of clinical variables and cognitive reserve in preserving the integrity of the neuropsychological profile. In this paper, we hypothesised that a higher level of CR might predict good cognitive efficiency by modulating the clinical outcome of the disease. (ii) Methods: A sample of 100 participants with MS (age range 30–74), was recruited and assessed remotely with a questionnaire to measure CR and a cognitive screening test. Data were analysed through generalized additive models. (iii) Results: We found that the model analysing the interaction between CR and disease duration, and between CR and motor disability, was able to explain a significant percentage of cognitive performance. In particular, higher levels of CR predicted a better cognitive performance despite a long disease duration, unless the motor disability was severe. (iv) Conclusion: This study highlights the crucial role of CR in modulating cognitive efficiency in people with MS. MDPI 2023-08-25 /pmc/articles/PMC10525733/ /pubmed/37753986 http://dx.doi.org/10.3390/bs13090708 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Maffezzini, Sabrina
Pucci, Veronica
Riccardi, Alice
Montemurro, Sonia
Puthenparampil, Marco
Perini, Paola
Rinaldi, Francesca
Gallo, Paolo
Arcara, Giorgio
Mondini, Sara
Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration
title Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration
title_full Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration
title_fullStr Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration
title_full_unstemmed Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration
title_short Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration
title_sort clinical profiles in multiple sclerosis: cognitive reserve and motor impairment along disease duration
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525733/
https://www.ncbi.nlm.nih.gov/pubmed/37753986
http://dx.doi.org/10.3390/bs13090708
work_keys_str_mv AT maffezzinisabrina clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration
AT pucciveronica clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration
AT riccardialice clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration
AT montemurrosonia clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration
AT puthenparampilmarco clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration
AT perinipaola clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration
AT rinaldifrancesca clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration
AT gallopaolo clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration
AT arcaragiorgio clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration
AT mondinisara clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration